JV9-42580-62641
1 vaccination
1 coded response
3 check-ins
1 free-text entry
0 call cases
- Sex
- Male
- Age at first dose
- 0-4
- ZIP prefix
- 650 / MO
- Registered
- 2022-07-02
- Relationship
- Child or adolescent in my care
- Guardian
- RU9-19401-75677
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-07-01
Dose 1 — Pfizer-BioNTech
-
2022-07-02
Registered in v-safe
- 2022-07-02
-
2022-07-03
Health check-in — days 1–6 daily, dose 1, under 3Feeling: Good · Vomiting, DiarrheaUnder 3 check-in
-
2022-07-15
Survey response — day 14, dose 1, under 3MedDRA: Lethargy, Pyrexia, Respiratory tract congestion, Rhinorrhoea — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Fever, runny nose, congestion, lethargicMedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-07-01 | Pfizer-BioNTech | No |
Free text
Release 12 (Under 3) — day 14, dose 1, under 3
Symptoms: Fever, runny nose, congestion, lethargic
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Lethargy | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release